Intervention not reported
Blood‐feeding success (washed nets) · Anopheles gambiae complex or Anopheles funestus group
The intervention showed no clear difference in blood‐feeding success (washed nets) (low certainty).
1 finding from 1 review
RR 1.07 [0.49, 2.33]
Studies not reported
Low
Intervention not reported
Mosquito mortality (unwashed nets) · Anopheles gambiae complex or Anopheles funestus group
The intervention showed no clear difference in mosquito mortality (unwashed nets) (low certainty).
1 finding from 1 review
RR 1.2 [0.64, 2.26]
Studies not reported
Low
Intervention not reported
Mosquito mortality (washed nets) · Anopheles gambiae complex or Anopheles funestus group
The intervention showed no clear difference in mosquito mortality (washed nets) (low certainty).
1 finding from 1 review
RR 1.07 [0.92, 1.25]
Studies not reported
Low
Intervention not reported
Blood‐feeding success (unwashed nets) · Anopheles gambiae complex or Anopheles funestus group
It is very uncertain whether the intervention changes blood‐feeding success (unwashed nets) (very low certainty).
1 finding from 1 review
RR 0.52 [0.12, 2.22]
Studies not reported
Very low
Intervention not reported
Parasite prevalence (9‐ to 12‐month · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention probably leads to lower parasite prevalence (9‐ to 12‐month (moderate certainty).
1 finding from 1 review
Intervention not reported
Blood‐feeding success (washed nets) · Anopheles gambiae complex or Anopheles funestus group
It is very uncertain whether the intervention changes blood‐feeding success (washed nets) (very low certainty).
1 finding from 1 review
RR 1.25 [0.82, 1.91]
Studies not reported
Very low
Intervention not reported
Parasite prevalence (16‐ to 18‐month · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention showed no clear difference in parasite prevalence (16‐ to 18‐month (moderate certainty).
1 finding from 1 review
Intervention not reported
Parasite prevalence (21‐ to 25‐month · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention probably leads to lower parasite prevalence (21‐ to 25‐month (moderate certainty).
1 finding from 1 review
Intervention not reported
Mosquito mortality (unwashed nets) · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention leads to higher mosquito mortality (unwashed nets) (high certainty).
1 finding from 1 review
Intervention not reported
Mosquito mortality (washed nets) · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
It is very uncertain whether the intervention changes mosquito mortality (washed nets) (very low certainty).
1 finding from 1 review
Intervention not reported
Blood‐feeding success (unwashed nets) · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention leads to lower blood‐feeding success (unwashed nets) (high certainty).
1 finding from 1 review
Intervention not reported
Blood‐feeding success (washed nets) · adults and childen living in malaria‐endemic areas, Anopheles gambiae complex or Anopheles funestus group
The intervention leads to lower blood‐feeding success (washed nets) (high certainty).
1 finding from 1 review
Intervention not reported
Mosquito mortality (unwashed nets) · Anopheles gambiae complex or Anopheles funestus group
The intervention probably leads to higher mosquito mortality (unwashed nets) (moderate certainty).
1 finding from 1 review
RR 1.68 [1.33, 2.11]
Studies not reported
Moderate
Intervention not reported
Overall survival ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Quality of life ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Any adverse events ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Any serious adverse events ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Cytokine release syndrome ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Progression‐free survival ( · people with relapsed or refractory DLBCL
1 finding from 1 review
Intervention not reported
Complete response ( · people with relapsed or refractory DLBCL
1 finding from 1 review